Sixth Wave Innovations INC WKN: A2PK5X ISIN: CA83011Y1088 Ticker-Symbol: AHUH (Seite 17)
eröffnet am 20.02.20 20:47:47 von
neuester Beitrag 20.05.23 12:14:51 von
neuester Beitrag 20.05.23 12:14:51 von
Beiträge: 616
ID: 1.320.607
ID: 1.320.607
Aufrufe heute: 0
Gesamt: 63.546
Gesamt: 63.546
Aktive User: 0
ISIN: CA83011Y3068 · WKN: A3EVVN
0,0090
EUR
0,00 %
0,0000 EUR
Letzter Kurs 09.01.24 Lang & Schwarz
Werte aus der Branche Nanotechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 43,55 | +0,58 | |
| 1,8570 | +0,38 | |
| 70,50 | 0,00 | |
| 2,7150 | 0,00 | |
| 4,7800 | -0,21 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 29,65 | -1,17 | |
| 206,00 | -1,90 | |
| 1,6800 | -3,45 | |
| 1,0200 | -5,56 | |
| 1,3450 | -5,94 |
Beitrag zu dieser Diskussion schreiben
Feedback
Übersetzt mit Deepl:
16. November 2021
https://sixthwave.com
info@sixthwave.com
CSE:SIXW | OTCQB:SIXWF | FSE:AHUH
Sixth Wave und York University entwickeln gemeinsam ein
Fluorometrisches mikrofluidisches AMIPs-Gerät
Halifax, Nova Scotia - (November 16, 2021) - Sixth Wave Innovations Inc. (CSE:SIXW) (OTCQB:SIXWF) (FSE:AHUH) ("Sixth Wave", "SIXW" oder das "Unternehmen") freut sich, ein Update über die Entwicklung seiner Accelerated Molecular Imprinted Polymers (AMIPs™) und die laufende Zusammenarbeit mit der York University zu geben.
Sixth Wave hat seine AMIP™-Technologie erfolgreich in ein mikrofluidisches Multikomponenten-Gerät mit Fluoreszenzdetektion integriert. Der Prototyp des Geräts, der von den Gruppen von Dr. Pouya Rezai und Dr. Satinder Brar an der York University entwickelt wurde, beschichtet fluoreszierende magnetische Mikropartikel mit einer dünnen Schicht AMIPs™-Polymer. Wenn die ultradünne AMIP™-Polymerhülle den Zielerreger bindet, wird eine Veränderung des Fluoreszenzsignals durch das Gerät erkannt. Die Integration der Detektoren in mikrofluidische Geräte und "Lab-on-a-Chip"-Designs ermöglicht das Screening auf mehrere Krankheitserreger mit einem einzigen Test/Gerät.
"Die Integration der AMIPs™-Technologie in ein komplexes Mehrkomponentensystem ist eine wichtige Leistung, mit der wir die Möglichkeiten unserer Produktentwicklung weiter ausbauen", erklärte Dr. Garrett Kraft, Vice President of Innovations bei Sixth Wave. "Die in dieses Gerät integrierten Technologien und Komponenten umfassen molekular geprägte Polymerbeschichtungen auf nicht-flachen Oberflächen, magnetische fluoreszierende Mikropartikel, Mikrofluidik mit Magnetfeldmanipulation und fluoreszierende Bildgebung mit integrierter Bildanalysesoftware."
Weitere Forschungs- und Entwicklungsarbeiten werden die technischen Parameter des Geräts, einschließlich Empfindlichkeit und Spezifität, charakterisieren. Sixth Wave schafft eine grundlegende Basis, die die Integration anderer fortschrittlicher Technologien wie künstliche Intelligenz, maschinelles Lernen und Automatisierung mit der AMIPs™-Technologie ermöglicht. Die Sixth-Wave-Technologien sollen vor allem bei der Verwaltung eines großen Netzwerks von Geräten und der Überwachung von Metadaten aus großen Populationen in Echtzeit nützlich sein. Das aktuelle Gerät kann in einer Konfiguration mit kontinuierlicher Überwachung betrieben werden.
Die jüngsten Weiterentwicklungen der AMIPs™-Technologie von Sixth Wave und die nachgewiesene Integration in elektrische und fluoreszierende Detektoren haben die Flexibilität der Technologie bewiesen. Nachdem eine solide Grundlage geschaffen wurde, wird weiter an der Entwicklung der erforderlichen technischen Spezifikationen für jede Endanwendung gearbeitet. Zu den Anwendungen gehören die Personendiagnostik sowie das Hochdurchsatz-Screening von Luft-, Oberflächen- und Wassersystemen. Die Anwendungen in unterschiedlichen Umgebungen stellen unterschiedliche und einzigartige Herausforderungen dar. Die jüngsten Arbeiten tragen direkt zu neuartigen Lösungen für die Herausforderungen in jeder der oben genannten Endanwendungen bei.
Der Prototyp ist das Ergebnis des geistigen Eigentums, das in dem am 28. September 2021 eingereichten Patent beschrieben ist. Die Patentanmeldung mit dem Titel: MOLECULARLY IMPRINTED POLYMER COATINGS AND SENSORS FOR BIO DETECTION deckt das geistige Eigentum ab, das durch die Zusammenarbeit mit der York University entstanden ist. Die Arbeit mit der York University ist eine Erweiterung der Bemühungen von Sixth Wave mit der AMIPs™-Produktlinie und umfasst die Fähigkeit, sowohl virale als auch bakterielle Krankheitserreger in Flüssigkeitsproben nachzuweisen. Die frühen Ergebnisse sind Teil der langfristigen Pläne von SIXW, die AMIPs™-Technologie zu erweitern, um eine breite Palette von Zielerregern und Biomarkern nachzuweisen, die eine Veränderung des Gesundheitszustands und eine kontinuierliche Echtzeitüberwachung bestimmen.
Das Unternehmen setzt sein aggressives Forschungs- und Entwicklungsprogramm fort, das auf die Entwicklung einer breiten Palette von AMIPs™-Virus-/Bakterien-Schnellnachweisgeräten ausgerichtet ist. Das Spektrum der zukünftigen Produkte wird neben der SmartMask™ von SIXW auch intelligente Kleidung, PSA-Anwendungen, Luftsensoren, Atemalkoholtester, ELISA-basierte Technologien, Patronen-/Lateralflow-Designs und andere umfassen.
Wie bereits berichtet, hat SIXW drei Patente in Bezug auf die AMIPs™-Technologie und ihre Anwendung auf bestimmte Produkte, die AMIPs™ nutzen können, angemeldet. Das Unternehmen erhebt weder ausdrücklich noch stillschweigend den Anspruch, dass sein aktuelles AMIPs™-Produkt in der Lage ist, COVID-19 (oder SARS-2-Coronavirus) auf kommerzieller Ebene zu eliminieren, zu heilen, einzudämmen oder zu erkennen.
Übersetzt mit www.DeepL.com/Translator (kostenlose Version)
16. November 2021
https://sixthwave.com
info@sixthwave.com
CSE:SIXW | OTCQB:SIXWF | FSE:AHUH
Sixth Wave und York University entwickeln gemeinsam ein
Fluorometrisches mikrofluidisches AMIPs-Gerät
Halifax, Nova Scotia - (November 16, 2021) - Sixth Wave Innovations Inc. (CSE:SIXW) (OTCQB:SIXWF) (FSE:AHUH) ("Sixth Wave", "SIXW" oder das "Unternehmen") freut sich, ein Update über die Entwicklung seiner Accelerated Molecular Imprinted Polymers (AMIPs™) und die laufende Zusammenarbeit mit der York University zu geben.
Sixth Wave hat seine AMIP™-Technologie erfolgreich in ein mikrofluidisches Multikomponenten-Gerät mit Fluoreszenzdetektion integriert. Der Prototyp des Geräts, der von den Gruppen von Dr. Pouya Rezai und Dr. Satinder Brar an der York University entwickelt wurde, beschichtet fluoreszierende magnetische Mikropartikel mit einer dünnen Schicht AMIPs™-Polymer. Wenn die ultradünne AMIP™-Polymerhülle den Zielerreger bindet, wird eine Veränderung des Fluoreszenzsignals durch das Gerät erkannt. Die Integration der Detektoren in mikrofluidische Geräte und "Lab-on-a-Chip"-Designs ermöglicht das Screening auf mehrere Krankheitserreger mit einem einzigen Test/Gerät.
"Die Integration der AMIPs™-Technologie in ein komplexes Mehrkomponentensystem ist eine wichtige Leistung, mit der wir die Möglichkeiten unserer Produktentwicklung weiter ausbauen", erklärte Dr. Garrett Kraft, Vice President of Innovations bei Sixth Wave. "Die in dieses Gerät integrierten Technologien und Komponenten umfassen molekular geprägte Polymerbeschichtungen auf nicht-flachen Oberflächen, magnetische fluoreszierende Mikropartikel, Mikrofluidik mit Magnetfeldmanipulation und fluoreszierende Bildgebung mit integrierter Bildanalysesoftware."
Weitere Forschungs- und Entwicklungsarbeiten werden die technischen Parameter des Geräts, einschließlich Empfindlichkeit und Spezifität, charakterisieren. Sixth Wave schafft eine grundlegende Basis, die die Integration anderer fortschrittlicher Technologien wie künstliche Intelligenz, maschinelles Lernen und Automatisierung mit der AMIPs™-Technologie ermöglicht. Die Sixth-Wave-Technologien sollen vor allem bei der Verwaltung eines großen Netzwerks von Geräten und der Überwachung von Metadaten aus großen Populationen in Echtzeit nützlich sein. Das aktuelle Gerät kann in einer Konfiguration mit kontinuierlicher Überwachung betrieben werden.
Die jüngsten Weiterentwicklungen der AMIPs™-Technologie von Sixth Wave und die nachgewiesene Integration in elektrische und fluoreszierende Detektoren haben die Flexibilität der Technologie bewiesen. Nachdem eine solide Grundlage geschaffen wurde, wird weiter an der Entwicklung der erforderlichen technischen Spezifikationen für jede Endanwendung gearbeitet. Zu den Anwendungen gehören die Personendiagnostik sowie das Hochdurchsatz-Screening von Luft-, Oberflächen- und Wassersystemen. Die Anwendungen in unterschiedlichen Umgebungen stellen unterschiedliche und einzigartige Herausforderungen dar. Die jüngsten Arbeiten tragen direkt zu neuartigen Lösungen für die Herausforderungen in jeder der oben genannten Endanwendungen bei.
Der Prototyp ist das Ergebnis des geistigen Eigentums, das in dem am 28. September 2021 eingereichten Patent beschrieben ist. Die Patentanmeldung mit dem Titel: MOLECULARLY IMPRINTED POLYMER COATINGS AND SENSORS FOR BIO DETECTION deckt das geistige Eigentum ab, das durch die Zusammenarbeit mit der York University entstanden ist. Die Arbeit mit der York University ist eine Erweiterung der Bemühungen von Sixth Wave mit der AMIPs™-Produktlinie und umfasst die Fähigkeit, sowohl virale als auch bakterielle Krankheitserreger in Flüssigkeitsproben nachzuweisen. Die frühen Ergebnisse sind Teil der langfristigen Pläne von SIXW, die AMIPs™-Technologie zu erweitern, um eine breite Palette von Zielerregern und Biomarkern nachzuweisen, die eine Veränderung des Gesundheitszustands und eine kontinuierliche Echtzeitüberwachung bestimmen.
Das Unternehmen setzt sein aggressives Forschungs- und Entwicklungsprogramm fort, das auf die Entwicklung einer breiten Palette von AMIPs™-Virus-/Bakterien-Schnellnachweisgeräten ausgerichtet ist. Das Spektrum der zukünftigen Produkte wird neben der SmartMask™ von SIXW auch intelligente Kleidung, PSA-Anwendungen, Luftsensoren, Atemalkoholtester, ELISA-basierte Technologien, Patronen-/Lateralflow-Designs und andere umfassen.
Wie bereits berichtet, hat SIXW drei Patente in Bezug auf die AMIPs™-Technologie und ihre Anwendung auf bestimmte Produkte, die AMIPs™ nutzen können, angemeldet. Das Unternehmen erhebt weder ausdrücklich noch stillschweigend den Anspruch, dass sein aktuelles AMIPs™-Produkt in der Lage ist, COVID-19 (oder SARS-2-Coronavirus) auf kommerzieller Ebene zu eliminieren, zu heilen, einzudämmen oder zu erkennen.
Übersetzt mit www.DeepL.com/Translator (kostenlose Version)
Sixth Wave Achieves Electrical Detection
with AMIPs™ Technology
Halifax, Nova Scotia – (November 10, 2021) – Sixth Wave Innovations Inc. (CSE:SIXW) (OTCQB:SIXWF) (FSE:AHUH) (“Sixth Wave”, “SIXW” or the “Company”) is pleased to provide an update on the Company’s Accelerated Molecular Imprinted Polymers (AMIPs™) and collaboration with York University.
Sixth Wave has successfully demonstrated the ability to identify the capture of pathogens electrically with one of its AMIPs™ prototypes. The prototype device created at York University integrates SIXW’s AMIPs™ technology into an electrical sensor by coating the electrical sensor with AMIP™ polymer. When the AMIPs™ selectively binds with the target pathogen, a corresponding electrical signal is detected by the device.
This breakthrough enables the integration of AMIPs™ with RFID chips for transmission of pathogen detection to smartphones or other wireless device readers, allowing for air monitoring, and other novel applications. Importantly, sample processing using electrical detection is reduced and can be automated for critical applications such as high-throughput screening including densely populated spaces such as schools, hospitals, eldercare facilities, sports and entertainment venues, transportation systems and places of work. It also allows for environmental monitoring for early detection and outbreak monitoring across larger groups of people.
Further research and development will characterize the device’s technical parameters including sensitivity and specificity measurements.
“Achieving electrical detection is a major technical milestone for us.” Said Dr. Garrett Kraft, Vice President of Innovation at Sixth Wave. “Our vision for what AMIPs™ can accomplish is reliant on pairing our MIP technology with electrical sensors. Now that the proof-of-principle for that vision has been achieved, we are making rapid progress toward our end goal of launching our innovative technology to meet unfulfilled demand by offering multiple applications in traditional and non-traditional settings.”
The work also directly contributes to the integration of the detectors with microfluidics devices and lab-on-a-chip designs to screen for multiple pathogens with a single test.
The prototype is a result of the intellectual property detailed in the patent filed on September 28, 2021. The patent application Title: MOLECULARLY IMPRINTED POLYMER COATINGS AND SENSORS FOR BIODETECTION, covers the intellectual property generated by the collaboration with York University. The work with York University is an expansion of Sixth Wave’s efforts with the AMIPs™ product line and covers the capabilities of detecting both viral and bacterial based pathogens in fluid samples. These early-stage results are apart of SIXW”s long term plans of expanding the AMIPs™ technology to detect a wide range of target pathogens and biomarkers for detecting a change in health status and continuous real-time monitoring.
The Company continues to progress through an aggressive R&D program geared toward developing a wide range of AMIPs™ Virus/Bacteria rapid detection devices. The spectrum of prospective products will include SIXW’s SmartMask™ offerings (see SIXW Press Release dated May 15, 2020), in addition to smart-clothing, PPE applications, airborne sensors, breathalyzers, ELISA-based technologies, cartridge/lateral flow designs, and others.
As previously reported, SIXW has filed three patents regarding the AMIPs™ technology and its application to specific products that can utilize AMIPs™. The Company is not making any express or implied claims that its current AMIPs™ product has the ability to eliminate, cure, contain, or detect, at a commercial level, COVID-19 (or SARS-2 coronavirus) at this time.
For more information on the AMIPs™ and associated molecular imprinting technology, please visit: https://www.amips.com
with AMIPs™ Technology
Halifax, Nova Scotia – (November 10, 2021) – Sixth Wave Innovations Inc. (CSE:SIXW) (OTCQB:SIXWF) (FSE:AHUH) (“Sixth Wave”, “SIXW” or the “Company”) is pleased to provide an update on the Company’s Accelerated Molecular Imprinted Polymers (AMIPs™) and collaboration with York University.
Sixth Wave has successfully demonstrated the ability to identify the capture of pathogens electrically with one of its AMIPs™ prototypes. The prototype device created at York University integrates SIXW’s AMIPs™ technology into an electrical sensor by coating the electrical sensor with AMIP™ polymer. When the AMIPs™ selectively binds with the target pathogen, a corresponding electrical signal is detected by the device.
This breakthrough enables the integration of AMIPs™ with RFID chips for transmission of pathogen detection to smartphones or other wireless device readers, allowing for air monitoring, and other novel applications. Importantly, sample processing using electrical detection is reduced and can be automated for critical applications such as high-throughput screening including densely populated spaces such as schools, hospitals, eldercare facilities, sports and entertainment venues, transportation systems and places of work. It also allows for environmental monitoring for early detection and outbreak monitoring across larger groups of people.
Further research and development will characterize the device’s technical parameters including sensitivity and specificity measurements.
“Achieving electrical detection is a major technical milestone for us.” Said Dr. Garrett Kraft, Vice President of Innovation at Sixth Wave. “Our vision for what AMIPs™ can accomplish is reliant on pairing our MIP technology with electrical sensors. Now that the proof-of-principle for that vision has been achieved, we are making rapid progress toward our end goal of launching our innovative technology to meet unfulfilled demand by offering multiple applications in traditional and non-traditional settings.”
The work also directly contributes to the integration of the detectors with microfluidics devices and lab-on-a-chip designs to screen for multiple pathogens with a single test.
The prototype is a result of the intellectual property detailed in the patent filed on September 28, 2021. The patent application Title: MOLECULARLY IMPRINTED POLYMER COATINGS AND SENSORS FOR BIODETECTION, covers the intellectual property generated by the collaboration with York University. The work with York University is an expansion of Sixth Wave’s efforts with the AMIPs™ product line and covers the capabilities of detecting both viral and bacterial based pathogens in fluid samples. These early-stage results are apart of SIXW”s long term plans of expanding the AMIPs™ technology to detect a wide range of target pathogens and biomarkers for detecting a change in health status and continuous real-time monitoring.
The Company continues to progress through an aggressive R&D program geared toward developing a wide range of AMIPs™ Virus/Bacteria rapid detection devices. The spectrum of prospective products will include SIXW’s SmartMask™ offerings (see SIXW Press Release dated May 15, 2020), in addition to smart-clothing, PPE applications, airborne sensors, breathalyzers, ELISA-based technologies, cartridge/lateral flow designs, and others.
As previously reported, SIXW has filed three patents regarding the AMIPs™ technology and its application to specific products that can utilize AMIPs™. The Company is not making any express or implied claims that its current AMIPs™ product has the ability to eliminate, cure, contain, or detect, at a commercial level, COVID-19 (or SARS-2 coronavirus) at this time.
For more information on the AMIPs™ and associated molecular imprinting technology, please visit: https://www.amips.com
Sixth Wave to Develop Environmentally
Friendly Green Lixiviants for Mining
Halifax, Nova Scotia – (October 27, 2021) – Sixth Wave Innovations Inc. (CSE:SIXW) (OTCQB:SIXWF) (FSE:AHUH) (“Sixth Wave”, “SIXW” or the “Company”) is pleased to provide an update on the Company’s growing patent portfolio. The company has signed a Letter of Intent (LOI) and Assignment Agreement with Sara Magdouli, Ph.D. and Ali Entezari-Zarandi, Ph.D. The parties will collaborate on the development of “green lixiviants” as an alternative to conventional chemical reagents for recovery of Gold (Au), Lithium (Li), Rare Earth Elements (REE), and other metals. A lixiviant is a liquid medium used in hydrometallurgy to selectively extract the desired metal from the ore or mineral. It assists in rapid and complete leaching, for example during in situ leaching. The metal can be recovered from it in a concentrated form after leaching. The patent will be solely in the name of Sixth Wave and the company will have exclusive ownership of the IP, subject to a reasonably agreed-upon license fee to the co-inventors.
This work has led to the development of various novel reagent formulations capable of dissolving gold from concentrates with promising results in terms of its potential use for treatment of hard-to-leach or refractory golds. “We are highly motivated to pursue our collaborative efforts regarding green research and development opportunities” states Sherman McGill, Executive Vice-President of Sixth Wave, Inc. “Adding this technology to the Company’s line of IXOS® nanotech extraction polymers used for gold mining will greatly broaden the company’s innovative portfolio of products available to the global mining industry. Mining companies are aggressively looking for “green lixiviants” that use innovative, cutting-edge technology to mine metals that have explosive global demand such as Lithium, Cobalt, and REEs.”
Green lixiviants garner attention due to their unique properties which are mostly non-toxic and biodegradable with negligible or no vapor. Environmental and social responsibility are vitally important components of Sixth Wave’s corporate culture and are increasingly mandated by governmental regulation. Therefore, increased research devoted to metal recovery using environmentally friendly lixiviants for high-value targets such as Li, Co, (REEs) from spent magnets, and rare earth carbonate mineral, as well as zinc and lead removal from electric arc furnace dusts should prove very profitable to the company.
Friendly Green Lixiviants for Mining
Halifax, Nova Scotia – (October 27, 2021) – Sixth Wave Innovations Inc. (CSE:SIXW) (OTCQB:SIXWF) (FSE:AHUH) (“Sixth Wave”, “SIXW” or the “Company”) is pleased to provide an update on the Company’s growing patent portfolio. The company has signed a Letter of Intent (LOI) and Assignment Agreement with Sara Magdouli, Ph.D. and Ali Entezari-Zarandi, Ph.D. The parties will collaborate on the development of “green lixiviants” as an alternative to conventional chemical reagents for recovery of Gold (Au), Lithium (Li), Rare Earth Elements (REE), and other metals. A lixiviant is a liquid medium used in hydrometallurgy to selectively extract the desired metal from the ore or mineral. It assists in rapid and complete leaching, for example during in situ leaching. The metal can be recovered from it in a concentrated form after leaching. The patent will be solely in the name of Sixth Wave and the company will have exclusive ownership of the IP, subject to a reasonably agreed-upon license fee to the co-inventors.
This work has led to the development of various novel reagent formulations capable of dissolving gold from concentrates with promising results in terms of its potential use for treatment of hard-to-leach or refractory golds. “We are highly motivated to pursue our collaborative efforts regarding green research and development opportunities” states Sherman McGill, Executive Vice-President of Sixth Wave, Inc. “Adding this technology to the Company’s line of IXOS® nanotech extraction polymers used for gold mining will greatly broaden the company’s innovative portfolio of products available to the global mining industry. Mining companies are aggressively looking for “green lixiviants” that use innovative, cutting-edge technology to mine metals that have explosive global demand such as Lithium, Cobalt, and REEs.”
Green lixiviants garner attention due to their unique properties which are mostly non-toxic and biodegradable with negligible or no vapor. Environmental and social responsibility are vitally important components of Sixth Wave’s corporate culture and are increasingly mandated by governmental regulation. Therefore, increased research devoted to metal recovery using environmentally friendly lixiviants for high-value targets such as Li, Co, (REEs) from spent magnets, and rare earth carbonate mineral, as well as zinc and lead removal from electric arc furnace dusts should prove very profitable to the company.
Antwort auf Beitrag Nr.: 69.640.236 von wrkmq am 19.10.21 17:52:31Ja, sollte das alles entsprechend funktionieren, dann werden wir viel Freude haben.
Und lt. Gluckman sollen die Firmen ja schon Schlange stehen.
Es sollte aber in 2022 einiges bzgl Ixos kommen, insbesondere bei Rio habe
Ich den Eindruck, die wollen das in ihrer Mine haben.
Wenn die beiden Dinger laufen wie geplant, dann bin ich auf den Kurs gespannt.
Aber wie gesagt: wenn
Und lt. Gluckman sollen die Firmen ja schon Schlange stehen.
Es sollte aber in 2022 einiges bzgl Ixos kommen, insbesondere bei Rio habe
Ich den Eindruck, die wollen das in ihrer Mine haben.
Wenn die beiden Dinger laufen wie geplant, dann bin ich auf den Kurs gespannt.
Aber wie gesagt: wenn
Wow!:
"...The entry-level production Affinity™ System will be capable of generating recurring revenue of approximately CAD$2.25M annually based on a 300-day production schedule..."
Die kleine Kiste soll also schon 2,25 Mio Umsatz machen. Allein Affinity kann uns schon in 2022 sehr glücklich machen. Ist und bleibt der top-pic für mich (!) für 2022 und auch folgende Jahre. Kiffe zwar nicht, bin nun aber auch ganz klar für eine Canabis-Legalisierug in D bzw. EU :-)
"...The entry-level production Affinity™ System will be capable of generating recurring revenue of approximately CAD$2.25M annually based on a 300-day production schedule..."
Die kleine Kiste soll also schon 2,25 Mio Umsatz machen. Allein Affinity kann uns schon in 2022 sehr glücklich machen. Ist und bleibt der top-pic für mich (!) für 2022 und auch folgende Jahre. Kiffe zwar nicht, bin nun aber auch ganz klar für eine Canabis-Legalisierug in D bzw. EU :-)
Trading Spotlight
Sixth Wave Updates on Delivery of Affinity™ System
Halifax, Nova Scotia – (Oct. 19, 2021) – Sixth Wave Innovations Inc. (CSE:SIXW) (OTCQB:SIXWF) (FSE:AHUH) (“Sixth Wave”, “SIXW” or the “Company”) is pleased to provide an update on the delivery of its Affinity™ System (the “System”) for purification of cannabinoids. The Company has received the first of three Affinity™ Systems at its proving lab in Baltimore, Maryland from its production partner, Advanced Extraction Systems Inc.
The System will undergo a structured testing protocol to verify operation and final configuration for subsequent delivery to Green Envy Extracts pending Green Envy receiving final site approval from the State of Michigan. Commissioning work will take place at Green Envy, to be followed by a 60-day confirmatory operation period. Sixth Wave will conduct a site visit to refine the installation plan with Green Envy and the facility owners, Medpharm Holdings (https://medpharmholdings.com) on Oct. 25, 2021.
Reduced Processing Cost, Increased Yield and Purity
Processing costs associated with the Affinity™ System are expected to be lower than traditional technology by $0.25 to $0.50 per gram of cannabinoids produced.
Sixth Wave estimates that the unit will be capable of delivering an increase in cannabinoid yield by more than 20% over traditional technologies. This increased yield, assuming a wholesale price of only $1,000/kg of product, would result in $200/kg incremental revenue to Affinity customers.
Further, the Affinity™ System is expected to result in a higher purity product, containing up to 90% cannabinoids, an increase from roughly 80% cannabinoid content traditionally generated by distillation. The Company expects that this improved purity could allow Affinity users to command a premium price for their product.
Total System Performance Licence (“TSPL”)
The Company intends to introduce the Affinity™ System to the market under its Total System Performance License (TSPL) program, fashioned after US Federal Acquisition Reform (FAR) guidelines. The Company will sell Affinity™ Systems to licensed producers at a price commensurate to the size of the system and will charge a fee based on the actual throughput or usage. In return, the licensed producer will have SIXW’s full support, installation and configuration management, GMP qualification support, 100% warrantee on all equipment, replacement and upgrade of the Affinity™ System nanotech purification media, and 24/7 technical support for as long as minimum production levels are maintained.
The Company expects to earn roughly CAD$0.25 / finished gram of product through the TSPL fee (based on production levels of less than 20kg per day).
Production Levels
Based on current standard operating procedures (SOP), the initial system being delivered to Green Envy/Medpharm is capable of processing approximately 6kg of final, high purity distillate every 10hrs of operation. The larger production unit scheduled for delivery in late December 2021, will be capable of producing finished distillate of approximately 14kg/10hrs of operation or in excess of 30kg/day thereby surpassing the Company’s original 20kg/day goal.
The entry-level production Affinity™ System will be capable of generating recurring revenue of approximately CAD$2.25M annually based on a 300-day production schedule. A portion of the proceeds will be set aside to support TSPL requirements while the remaining will be used for quality improvement program (QIP), research and development, operations, and profit. The Company is entering initial product roll-out and specific TSPL costs are not fully established. The Company will use industry averages for similar manufactured goods as a baseline and will adjust as historic data for the Affinity™ System becomes available.
As noted by Dr. Jon Gluckman, President and CEO of Sixth Wave, “Our goal is to be a leader in purification today and well into the future. We want our customers to feel like we are invested in their success as opposed to simply supplying equipment. As such, the basic principle behind the TSPL program is Sixth Wave makes money when our customers are successfully processing with the Affinity™ System. If the System is down, we need to get it operational ASAP and are as motivated as our customers. The TSPL allows for a cooperative relationship and helps ensure that our customers always have the latest upgrades etc. without having to worry about additional or unknown costs. We are confident that the Affinity™ System and accompanying TSPL program will significantly reduce processing costs, increase yield and provide competitive advantages in profitability and product quality for our customers.”
The Company is in discussions with several new early adopters and expects to be opening up sales to the industry at large before the end of the year. Sixth Wave has received inquiries from over 100 licensed producers with roughly half being in North America and the remaining worldwide. Inquiries have come from a mix of hemp and cannabis producers. The Company is currently gearing up production and ordering long-lead components to avoid possible delays in roll-out caused by ongoing global supply chain issues.
Halifax, Nova Scotia – (Oct. 19, 2021) – Sixth Wave Innovations Inc. (CSE:SIXW) (OTCQB:SIXWF) (FSE:AHUH) (“Sixth Wave”, “SIXW” or the “Company”) is pleased to provide an update on the delivery of its Affinity™ System (the “System”) for purification of cannabinoids. The Company has received the first of three Affinity™ Systems at its proving lab in Baltimore, Maryland from its production partner, Advanced Extraction Systems Inc.
The System will undergo a structured testing protocol to verify operation and final configuration for subsequent delivery to Green Envy Extracts pending Green Envy receiving final site approval from the State of Michigan. Commissioning work will take place at Green Envy, to be followed by a 60-day confirmatory operation period. Sixth Wave will conduct a site visit to refine the installation plan with Green Envy and the facility owners, Medpharm Holdings (https://medpharmholdings.com) on Oct. 25, 2021.
Reduced Processing Cost, Increased Yield and Purity
Processing costs associated with the Affinity™ System are expected to be lower than traditional technology by $0.25 to $0.50 per gram of cannabinoids produced.
Sixth Wave estimates that the unit will be capable of delivering an increase in cannabinoid yield by more than 20% over traditional technologies. This increased yield, assuming a wholesale price of only $1,000/kg of product, would result in $200/kg incremental revenue to Affinity customers.
Further, the Affinity™ System is expected to result in a higher purity product, containing up to 90% cannabinoids, an increase from roughly 80% cannabinoid content traditionally generated by distillation. The Company expects that this improved purity could allow Affinity users to command a premium price for their product.
Total System Performance Licence (“TSPL”)
The Company intends to introduce the Affinity™ System to the market under its Total System Performance License (TSPL) program, fashioned after US Federal Acquisition Reform (FAR) guidelines. The Company will sell Affinity™ Systems to licensed producers at a price commensurate to the size of the system and will charge a fee based on the actual throughput or usage. In return, the licensed producer will have SIXW’s full support, installation and configuration management, GMP qualification support, 100% warrantee on all equipment, replacement and upgrade of the Affinity™ System nanotech purification media, and 24/7 technical support for as long as minimum production levels are maintained.
The Company expects to earn roughly CAD$0.25 / finished gram of product through the TSPL fee (based on production levels of less than 20kg per day).
Production Levels
Based on current standard operating procedures (SOP), the initial system being delivered to Green Envy/Medpharm is capable of processing approximately 6kg of final, high purity distillate every 10hrs of operation. The larger production unit scheduled for delivery in late December 2021, will be capable of producing finished distillate of approximately 14kg/10hrs of operation or in excess of 30kg/day thereby surpassing the Company’s original 20kg/day goal.
The entry-level production Affinity™ System will be capable of generating recurring revenue of approximately CAD$2.25M annually based on a 300-day production schedule. A portion of the proceeds will be set aside to support TSPL requirements while the remaining will be used for quality improvement program (QIP), research and development, operations, and profit. The Company is entering initial product roll-out and specific TSPL costs are not fully established. The Company will use industry averages for similar manufactured goods as a baseline and will adjust as historic data for the Affinity™ System becomes available.
As noted by Dr. Jon Gluckman, President and CEO of Sixth Wave, “Our goal is to be a leader in purification today and well into the future. We want our customers to feel like we are invested in their success as opposed to simply supplying equipment. As such, the basic principle behind the TSPL program is Sixth Wave makes money when our customers are successfully processing with the Affinity™ System. If the System is down, we need to get it operational ASAP and are as motivated as our customers. The TSPL allows for a cooperative relationship and helps ensure that our customers always have the latest upgrades etc. without having to worry about additional or unknown costs. We are confident that the Affinity™ System and accompanying TSPL program will significantly reduce processing costs, increase yield and provide competitive advantages in profitability and product quality for our customers.”
The Company is in discussions with several new early adopters and expects to be opening up sales to the industry at large before the end of the year. Sixth Wave has received inquiries from over 100 licensed producers with roughly half being in North America and the remaining worldwide. Inquiries have come from a mix of hemp and cannabis producers. The Company is currently gearing up production and ordering long-lead components to avoid possible delays in roll-out caused by ongoing global supply chain issues.
Antwort auf Beitrag Nr.: 69.583.548 von Synercon am 13.10.21 13:55:18👍 alles klar
Antwort auf Beitrag Nr.: 69.583.470 von Poseidon61 am 13.10.21 13:49:08dann warten wir einfach noch etwas ab. Bin gespannt welche Begründung dann kommt, falls wieder keine Umsätze erzielt werden.
Die alte Leier bei Dir!
Nochmal: Covidbedingte Verzögerungen in allen Bereichen, Reisen bis heute eingeschränkt. Für Dich kein Argument, kann und will ich nicht ändern.
Die Firma hat nie behauptet, mit Covid schnell Geld zu verdienen,
Quelle?
Startup-Hochrisiko-es geht vorwärts, dieses Jahr noch soll Affinity starten- wenn nicht Anfang nächstes Jahr-abwarten und neu bewerten.
Du investierst nicht, Dein Glück oder Dein Schaden, zeigt die Zukunft!
Nochmal: Covidbedingte Verzögerungen in allen Bereichen, Reisen bis heute eingeschränkt. Für Dich kein Argument, kann und will ich nicht ändern.
Die Firma hat nie behauptet, mit Covid schnell Geld zu verdienen,
Quelle?
Startup-Hochrisiko-es geht vorwärts, dieses Jahr noch soll Affinity starten- wenn nicht Anfang nächstes Jahr-abwarten und neu bewerten.
Du investierst nicht, Dein Glück oder Dein Schaden, zeigt die Zukunft!
Antwort auf Beitrag Nr.: 69.582.411 von Poseidon61 am 13.10.21 12:20:18Die Meldungen lauteten aber, es wird konkret ausgeliefert, es wurde bestellt. Und speziell mit Covid wollte man ja auch Geld verdienen. Die Covid-Ausrede gilt schon lange nicht mehr. Das war für die ersten Monate der harten Lockdowns legitim. Aber nicht 1 1/ 1/2 Jahre! Alle anderen Unternehmen bis auf Fluglinien, Großveranstaltungen etc. laufen bereits schon längst wieder voll oder nahezu voll.
Durchsuchen
